Monoclonal antibodies (mAbs) are laboratory-produced molecules that can bind to specific antigens. These antibodies are uniform, as they are derived from a single B-cell clone and are highly specific for a particular target. Initially developed for therapeutic uses in oncology, mAbs have expanded their application to various fields, including infectious diseases and autoimmune disorders.